Navigation Links
Multiple Presentations Featuring QNEXA® Data to be Presented at the European Congress on Obesity
Date:5/20/2011

MOUNTAIN VIEW, Calif., May 20, 2011 /PRNewswire/ -- VIVUS, Inc. (NASDAQ: VVUS) today announced that multiple abstracts will be presented at the upcoming European Congress on Obesity meeting to be held May 25 to May 28, 2011, at the ICEC Lutfi Kirdar Convention & Exhibition Center in Istanbul, Turkey.  The details of the presentations are as follows:Oral presentation:Friday, May 27 – Novel Drugs Session, Presentation time 17:15-17:30 (local time)Authors:  

Stephan Rossner, MD, PhD; Craig A. Peterson, MS; Barbara Troupin, MD, MBATitle:  

CARDIOMETABOLIC RISK REDUCTION IS DIRECTLY RELATED TO MAGNITUDE OF WEIGHT LOSS WITH LOW DOSE, CONTROLLED-RELEASE PHENTERMINE/TOPIRAMATE (PHEN/TPM CR) [T5:RS4.4]Poster presentations:Thursday, May 26– Hot Topic Poster Session, Presentation time 13:00-15:00 (local time)Authors:  

George A. Bray, MD; Louis J. Aronne, MD; Alok K. Gupta, MD; Wesley W. Day, PhD; Barbara Troupin, MD, MBATitle:  

EFFICACY AND TOLERABILITY OF TOPIRAMATE ALONE AND IN COMBINATION WITH PHENTERMINE [HTP.025]Friday, May 27– Poster Session, Presentation time 13:00-15:00 (local time)Authors:  

W. Timothy Garvey, MD; Craig A. Peterson, MS; Barbara Troupin, MD, MBATitle:  

WEIGHT LOSS WITH LOW-DOSE, CONTROLLED-RELEASE PHENTERMINE/TOPIRAMATE THERAPY IMPROVES GLYCAEMIC STATUS AND PREVENTS PROGRESSION TO TYPE 2 DIABETES MELLITUS [T5:P.102]Authors:  

W. Timothy Garvey, MD; Wesley W. Day, PhD, Charles H. Bowden, MDTitle:  

LONG-TERM TREATMENT WITH CONTROLLED-RELEASE PHENTERMINE/TOPIRAMATE DEMONSTRATES SUSTAINED WEIGHT LOSS OVER 108 WEEKS [T5:P.103]All posters will be displayed in the Exhibition Hall from the afternoon of May 25th until the morning of May 28th.

About QNEXA Controlled Release CapsulesQNEXA [kyoo-nek-suh] is an investigational drug c
'/>"/>

SOURCE VIVUS, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
2. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
3. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
4. Kosan Opens Registration Program for Lead Hsp90 Inhibitor, Tanespimycin, in Multiple Myeloma
5. Multiple NIH Phase 2 HIV Vaccine Trials Using Vicals Technology Produce Encouraging Results
6. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
7. Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma
8. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
9. Pharmacopeia Announces Positive Results from Phase 1 Multiple Ascending Dose Study of PS433540 (DARA)
10. Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints
11. Velcura Therapeutics, Inc. Reports Positive Pre-IND Meeting With FDA and Plans Early Clinical Trials for New Drug to Treat Multiple Myeloma Bone Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... York , September 2, 2014 ... published by Transparency Market Research "Latin America Home ... Devices, Therapeutic Home Healthcare Devices, Mobility Assist Devices ... Telemedicine, Respiratory Therapy, Infusion Therapy and Unskilled Home ... Trends and Forecast, 2014 - 2020" the Latin ...
(Date:9/2/2014)... -- According to the new market research ... by Material (Metal, Glass, Plastic), by Application [GC, LC ... published by MarketsandMarkets, the Chiral Chromatography Columns Market was ... grow at a CAGR of 5.2% from 2013 to ... 90 market data tables and 15 figures spread through ...
(Date:9/2/2014)... Calif. , Sept. 2, 2014  Avanir Pharmaceuticals, Inc. ... will present an overview of the company at the Morgan ... . , Presentation date: Tuesday September 9, 2014 ... A live webcast and 30-day archive of this presentation ... About Avanir Pharmaceuticals, Inc. Avanir Pharmaceuticals, Inc. is ...
Breaking Medicine Technology:Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 2Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 3Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 4Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 5Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 6Chiral Chromatography Column Market Worth $87.8 Million by 2018 2Chiral Chromatography Column Market Worth $87.8 Million by 2018 3Chiral Chromatography Column Market Worth $87.8 Million by 2018 4
... FRANCISCO, Calif., Aug. 25, 2011 Rigel Pharmaceuticals, Inc. ... M. Gower, chairman and chief executive officer, and Ryan ... Rigel, will present at two separate investor conferences in ... Healthcare Conference 2011Date: Thursday, September 8th at 10:20 a.m. ...
... Nutrastar International Inc. (OTCBB: NUIN; "Nutrastar" or the "Company"), ... Chinese Medicine ("TCM") consumer products, today announced that its ... under which Nutrastar may repurchase up to US$5 million ... 12 months. Under the program, the ...
Cached Medicine Technology:Nutrastar Announces Adoption of Share Repurchase Program 2Nutrastar Announces Adoption of Share Repurchase Program 3
(Date:9/2/2014)... Medex Analytic Services is delighted to ... Coral Springs, Fla. due to their greater than forecasted ... for the 2014 year by distinguishing Medex in the ... a higher level of service and professionalism in the ... the industry has responded.” , The location of the ...
(Date:9/2/2014)... The Dream2Walk Foundation along with Gas Monkey ... 2014 during Spinal Cord Injury Awareness Month featuring full band ... Chuck Ligon. Linear Automotive will be there hosting a Hot ... open at 2pm. The car show is Pre 1964 only, ... to the concert. There will be trophies for top 3 ...
(Date:9/2/2014)... September 03, 2014 Operators in the ... millions of people annually, arranging care and counsel for ... private enterprises are expected to derive $39.4 billion in ... and private income. Over the five years through 2014-15, ... rate of 6.6%, including growth of 4.1% in 2014-15. ...
(Date:9/2/2014)... Kathleen Doheny HealthDay Reporter ... U.S. obesity epidemic is a driving force behind the rising ... Researchers looked at data from five national surveys spanning ... in diabetes over time could be explained by factors such ... adults. The investigators found that the prevalence of diabetes ...
(Date:9/2/2014)... new studies further confirm the health benefits of breast-feeding. ... a lower risk of ear, throat and sinus infections ... similar trend when it comes to allergies. The ... immediate newborn period," said Dr. Jennifer Wu, an obstetrician-gynecologist ... was not involved in the new studies. The ...
Breaking Medicine News(10 mins):Health News:Medex Analytic Services Announces New Location for Corporate Headquarters 2Health News:Gas Monkey Hosts Concert in Dallas Benefiting Dream2Walk Foundation with Linear Automotive 2Health News:Community Services in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Community Services in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:Obesity Fueling Rise in Diabetes Rates, Study Finds 2Health News:Obesity Fueling Rise in Diabetes Rates, Study Finds 3Health News:More Evidence Breast-Feeding Lowers Child's Risk of Infections, Allergies 2
... said, ‘Self-critical adult who are prone to depression and anxiety, ... abused environment in their childhood years’. ,Verbally abused ... depression and anxiety as those who had not been verbally ... 54, conducted by Florida State University researchers revealed. ...
... Mr.Manmohan Singh today met representatives of the medical students ... The students came from institutions inside Delhi and across the ... demands which they wanted the Prime Minister and the government ... of their fellow students. ,The Prime Minister assured ...
... Health and Family Welfare Department into two wings, namely ... to allow for streamlined health services. ,State ... the step was being taken to ensure that specialist ... will ask 23 doctors who were on deputation with ...
... A politician's daughter in South Africa was embroiled in ... drugs in favour of a diet containing// garlic, olive ... believed to increase the lifetime of HIV victims’, said ... Treatment Action Campaign (TAC), said ‘Instead of objective decision-making ...
... Human Reproduction, researchers have established the first direct ... fertilization and Placenta Previa, a potentially dangerous complication ... a condition in which the placenta covers the ... baby’s passage in the birth canal. ...
... North Tripura district have been suffering from AIDS and 12 ... ,This was found in a survey at the ... ,The department collected blood samples of 120 inmates of ... HIV positive, the sources said., ,Refugee leader R Bhanglo, ...
Cached Medicine News:Health News:Link Established—Assisted Fertilization Can Complicate Pregnanc 2
... The 8600 Series Tabletop/Portable Digital ... universal tool for patient monitering. ... monitoring, the 8600 has earned ... worldwide and is recognized for ...
Halogen-free immersion oil based on ester oil....
Immersion oil composed on polyester polyol, diphenyl cresyl phosphate and tricyclodecane dimethanol....
Immersion oils may crystallize on storage. Can be redissolved on heating to 50ºC (1-2 hours)...
Medicine Products: